Supreme Court Chief Justice John Roberts may recuse himself from an upcoming ruling. Pharmaceuticals giant Wyeth was charged with negligence in a tort case related to the loss of a patient’s arm that was argued before the court last November, and is also the acquisition target of Pfizer, a company in which Chief Justice Roberts owns stock. The court decision would likely affect the value of Wyeth and therefore Pfizer’s value as well. Justice Roberts’ decision will likely set the precedent for these types of conflicts of interest. (law.com)
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=146082